These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dynamic contrast-enhanced MR imaging of the upper abdomen: enhancement properties of gadobutrol, gadolinium-DTPA-polylysine, and gadolinium-DTPA-cascade-polymer. Adam G; Neuerburg J; Spüntrup E; Mühler A; Scherer K; Günther RW Magn Reson Med; 1994 Nov; 32(5):622-8. PubMed ID: 7808263 [TBL] [Abstract][Full Text] [Related]
3. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns. Vexler VS; Clément O; Schmitt-Willich H; Brasch RC J Magn Reson Imaging; 1994; 4(3):381-8. PubMed ID: 8061437 [TBL] [Abstract][Full Text] [Related]
4. Comparison of gadolinium-DTPA and polylysine-gadolinium-DTPA--enhanced magnetic resonance imaging of hepatocarcinoma in the rat. Grandin C; Van Beers BE; Demeure R; Goudemant JF; Mottet I; Pringot J Invest Radiol; 1995 Oct; 30(10):572-81. PubMed ID: 8557496 [TBL] [Abstract][Full Text] [Related]
5. [Experimental evaluation of contrast medium enhanced high resolution MR angiography in the animal model. Gd-DTPA compared with Gd-DTPA-polylysine]. Vogl TJ; Hoffmann Y; Juergens M; Weinmann HJ; Mühler A; Yucel S; Felix R Radiologe; 1996 Mar; 36(3):254-62. PubMed ID: 8693090 [TBL] [Abstract][Full Text] [Related]
6. Dynamic MRI of a hypovascularized liver tumor model: comparison of a new blood pool contrast agent (24-gadolinium-DTPA-cascade-polymer) with gadopentetate dimeglumine. Tacke J; Adam G; Classen H; Mühler A; Prescher A; Günther RW J Magn Reson Imaging; 1997; 7(4):678-82. PubMed ID: 9243388 [TBL] [Abstract][Full Text] [Related]
7. [MRT of experimental liver abscesses: a comparison of a new blood pool contrast medium with gadolinium-DTPA in animal experiments]. Dick A; Adam G; Spüntrup E; Prescher A; Mühler A; Günther RW Rofo; 1996 Oct; 165(4):392-7. PubMed ID: 8963054 [TBL] [Abstract][Full Text] [Related]
8. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946 [TBL] [Abstract][Full Text] [Related]
9. Comparison of gadolinium-DTPA and macromolecular gadolinium-DTPA-polylysine for contrast-enhanced pulmonary time-of-flight magnetic resonance angiography. Böck JC; Kaufmann F; Felix R Invest Radiol; 1996 Oct; 31(10):652-7. PubMed ID: 8889654 [TBL] [Abstract][Full Text] [Related]
10. Acute occlusive ischemia of the rat intestine: early detection by MR imaging with polylysine-Gd-DTPA enhancement. Van Beers BE; Mottet I; Delos M; Goudemant JF; Demeure R; Pringot J J Magn Reson Imaging; 1995; 5(5):509-13. PubMed ID: 8574033 [TBL] [Abstract][Full Text] [Related]
12. Gadolinium-DTPA liposomes as a potential MRI contrast agent. Work in progress. Unger E; Needleman P; Cullis P; Tilcock C Invest Radiol; 1988 Dec; 23(12):928-32. PubMed ID: 3203995 [TBL] [Abstract][Full Text] [Related]
13. NMR imaging study of the pharmacodynamics of polylysine-gadolinium-DTPA in the rabbit and the rat. Van Hecke P; Marchal G; Bosmans H; Johannik K; Jiang Y; Vogler H; Van Ongeval C; Baert AL; Speck U Magn Reson Imaging; 1991; 9(3):313-21. PubMed ID: 1881249 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751 [TBL] [Abstract][Full Text] [Related]
15. Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography. Experimental study in rabbits. Loubeyre P; Canet E; Zhao S; Benderbous S; Amiel M; Revel D Invest Radiol; 1996 May; 31(5):288-93. PubMed ID: 8724128 [TBL] [Abstract][Full Text] [Related]
16. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Hamm B; Staks T; Mühler A; Bollow M; Taupitz M; Frenzel T; Wolf KJ; Weinmann HJ; Lange L Radiology; 1995 Jun; 195(3):785-92. PubMed ID: 7754011 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate. Kettritz U; Warshauer DM; Brown ED; Schlund JF; Eisenberg LB; Semelka RC Eur Radiol; 1996; 6(1):14-8. PubMed ID: 8797944 [TBL] [Abstract][Full Text] [Related]
18. Angiographic properties of Gd-DTPA-24-cascade-polymer--a new macromolecular MR contrast agent. Schwickert HC; Roberts TP; Mühler A; Stiskal M; Demsar F; Brasch RC Eur J Radiol; 1995 Jul; 20(2):144-50. PubMed ID: 7588870 [TBL] [Abstract][Full Text] [Related]
19. Dynamics of tumor imaging with Gd-DTPA-polyethylene glycol polymers: dependence on molecular weight. Desser TS; Rubin DL; Muller HH; Qing F; Khodor S; Zanazzi G; Young SW; Ladd DL; Wellons JA; Kellar KE J Magn Reson Imaging; 1994; 4(3):467-72. PubMed ID: 8061449 [TBL] [Abstract][Full Text] [Related]
20. Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs. Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H; Weinmann HJ Invest Radiol; 1996 Apr; 31(4):211-7. PubMed ID: 8721960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]